(Q37576591)
Statements
Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia (English)
S E M Herman
D Liu
A Wiestner
6 February 2013